Sort
48,018 grants matching “immunotherapy”
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer
$585,174Robert Page Edwards · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer
$585,127Maximilian Diehn · Stanford University · R01 · FY2023 · CA
Tumor-Associated Macrophages in Vasogenic Cerebral Edema in Brain Tumors
$585,044Dolores Hambardzumyan · University Of Pennsylvania · R01 · FY2025 · NS
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
$585,015Renier Joseph Brentjens · Roswell Park Cancer Institute Corp · U01 · FY2022 · CA
An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection
$585,004Steven Carl George · University Of California At Davis · R01 · FY2024 · EB
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
$584,972Evan Newell · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$584,931Wilfred Ngwa · Johns Hopkins University · R01 · FY2022 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$584,931Wilfred Ngwa · Johns Hopkins University · R01 · FY2023 · CA
Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors
$584,926Seth M Pollack · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$584,891Shruthi Naik · Mayo Clinic Rochester · U01 · FY2022 · CA
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
$584,868Gregoire Stephane Lauvau · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$584,840Anna Pomes · Indoor Biotechnologies · R01 · FY2021 · AI
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
$584,823A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$584,740Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$584,740Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model
$584,722Ryan C Fields · Washington University · R01 · FY2019 · CA
Intelligent treatment planning for cancer radiotherapy
$584,676Steve Bin Jiang · Ut Southwestern Medical Center · R01 · FY2019 · CA
Stanford Molecular Imaging Scholars (SMIS) Program
$584,648Craig S Levin · Stanford University · T32 · FY2024 · CA
Targeting the host immune response during sepsis
$584,642Guochang Hu · University Of Illinois At Chicago · R01 · FY2020 · HL
Decoding tumor metabolic and immunologic interactions driving racial disparity in African American patients with bladder cancer.
$584,631Nagireddy Putluri · Baylor College Of Medicine · R01 · FY2024 · CA
Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis
$584,578Natalia B Ivanova · University Of Georgia · R01 · FY2024 · HL
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapy
$584,575Bo Lu · University Of Missouri-Columbia · R01 · FY2024 · CA
Development of high parameter spatial transcriptomics and proteomics for the study of tumor microenvironments
$584,510Kimberly R Jordan · University Of Colorado Denver · R50 · FY2025 · CA
Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
$584,463John H Sampson · Duke University · R01 · FY2020 · CA
Metformin for chemoprevention of lung cancer in obese subjects at high risk
$584,429Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA